[Treatment of post-hemorrhagic hepatic encephalopathy in patients with cirrhosis].
Doffoël
M
M
Service d'Hépato-Gastroentérologie, Clinique Médicale B, CHU, Hôpital Central, Strasbourg.
Vetter
D
D
Bockel
R
R
D000596:Amino Acids / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001927:Brain Diseases / Q000209:etiology*; D004187:Disaccharides / Q000627:therapeutic use; D006471:Gastrointestinal Hemorrhage / Q000150:complications*; D006501:Hepatic Encephalopathy / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D018377:Neurotransmitter Agents / Q000627:therapeutic use
D000596:Amino Acids; D000900:Anti-Bacterial Agents; D004187:Disaccharides; D018377:Neurotransmitter Agents
Traitement de l'encéphalopathie hépatique post-hémorragique chez le cirrhotique.